Assessing liver fibrosis without biopsy in patients with HCV or NAFLD | Zendy

Tavankit Singh | Zendy; Daniela Allende | Zendy; Arthur J. McCullough | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Assessing liver fibrosis without biopsy in patients with HCV or NAFLD

Author(s) -

Tavankit Singh,

Daniela Allende,

Arthur J. McCullough

Publication year - 2019

Publication title -

cleveland clinic journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.359

H-Index - 63

eISSN - 1939-2869

pISSN - 0891-1150

DOI - 10.3949/ccjm.86a.17118

Subject(s) - medicine , nonalcoholic fatty liver disease , liver biopsy , fibrosis , liver fibrosis , gastroenterology , biopsy , hepatitis c virus , hepatitis c , chronic hepatitis , hepatic fibrosis , pathology , fatty liver , disease , virus , immunology

Staging of liver fibrosis is increasingly done using noninvasive methods, in some cases obviating the need for liver biopsy. Scores based on laboratory values and demographic variables have been developed and validated for assessing fibrosis in patients with hepatitis C virus (HCV) infection and nonalcoholic fatty liver disease (NAFLD), as have several imaging methods that measure shear-wave velocity, a reflection of fibrosis severity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research